Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News FluoroPharma Medical Inc FPMI

Healthcare Biotechnology
FluoroPharma Medical, Inc. is a biopharmaceutical company specializing in discovering, developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The Company is focused on the development of cardiovascular imaging agents that detect and assess acute and chronic forms of coronary artery disease (CAD). It has two clinical-stage molecular... see more

Recent & Breaking News (GREY:FPMI)

FluoroPharma Announces Appointment of Andrew H. Sassine to the Board of Directors

Marketwired March 11, 2014

Data Presented From FluoroPharma's Phase II Clinical Trial of CardioPET (18F FCPHA) for Assessment of Acute and Chronic Forms of Coronary Artery Disease (CAD)

Marketwired February 6, 2014

FluoroPharma CEO, Thijs Spoor, to Present Business and Portfolio Updates at the Noble Financial Capital Markets' Tenth Annual Equity Conference January 20, 2014

Marketwired January 15, 2014

FluoroPharma CEO Thijs Spoor to Provide Business and Portfolio Update at Biotech Showcase 2014 in San Francisco, January 13th-15th

Marketwired January 8, 2014

FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting

Marketwired December 19, 2013

FluoroPharma Medical Inc. to Present at the LD Micro Sixth Annual Conference on December 5, 2013

Marketwired November 27, 2013

FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA)

Marketwired November 25, 2013

FluoroPharma Medical, Inc. Names GE Healthcare Veteran, Edward L. Lyons, Jr. to Newly Created Position of Vice President, Marketing

Marketwired October 28, 2013

FluoroPharma Medical, Inc. Announces Closing of Equity Financing

Marketwired September 19, 2013

FluoroPharma Medical Announces Internal Review of Currently Acquired Imaging Data From Phase II Study for CardioPET(TM) (FCPHA)

Marketwired June 20, 2013

FluoroPharma Announces Appointment of Dr. Joseph A. Pierro to the Board of Directors

Marketwired April 15, 2013

FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT Imaging

Marketwired March 22, 2013

FluoroPharma Medical Announces Initial Data From Phase II Study for CardioPET(TM) (FCPHA)

Marketwired February 28, 2013

Protea Announces Two Additions to Its Board of Directors

Troy Schwensen February 6, 2013

FluoroPharma Medical, Inc. to Present at Noble Financial Conference

Marketwired January 22, 2013

Noble Financial January 22-23 Equity Conference Attracts More Than 100 Public Companies

Marketwired January 11, 2013

FluoroPharma Medical Announces Phase II Study for BFPET(TM) (18)F-TPP

Marketwired January 3, 2013

FluoroPharma Medical, Inc. to Present at Two Conferences Next Week

Marketwired January 2, 2013